期刊文献+

绝经后女性代谢综合征患者性激素水平改变及其与胰岛素抵抗的相关性 被引量:4

Relationship between serum sex hormone levels and insulin resistance in postmenopausal women with metabolic syndrome
下载PDF
导出
摘要 目的 探讨绝经后女性代谢综合征性激素水平的变化及其与胰岛素抵抗的相关性.方法 128例绝经后女性代谢综合征患者(代谢综合征组)和116名年龄相匹配的绝经后健康女性(对照组)均来2012年6-12月在山东省日照市人民医院健康查体中心的人群,所有研究对象均测量血压、身高、体质量,计算体重指数,测定空腹血糖、胰岛素、血脂和性激素水平.胰岛素、血清总睾酮、雌二醇检测采用电化学发光法,血清雌酮检测采用酶联免疫分析法.稳态模型评估法计算胰岛素抵抗指数(HOMA-IR)和胰岛素敏感指数(HOMA-ISI).结果 代谢综合征组患者体重指数、收缩压、舒张压、空腹血糖、三酰甘油水平均明显高于对照组[(26.6±2.2) kg/m2比(22.6±1.6) kg/m2,(129±10) mmHg(1mmHg=0.133 kPa)比(114 ±7) mmHg,(85±7)mmHg比(75±5)mmHg,(6.3±1.3) mmol/L比(5.0±0.4)mmol/L,(2.1±1.2)mmol/L比(0.9 ±0.3) mmol/L,均P<0.01],而高密度脂蛋白胆固醇(HDL-C)水平明显低于对照组[(1.36±0.35) mmol/L比(1.64±0.24)mmol/L,P<0.01];与对照组相比,代谢综合征组胰岛素、HOMA-IR明显增高(67.34 pmol/L比40.58 pmol/L,2.75比1.27;P<0.05或<0.01),而雌二醇、雌酮、HOMA-ISI明显降低(20.80 pmol/L比31.52 pmol/L,39.52 pmol/L比47.98 pmol/L,0.016比0.035,P<0.05或P<0.01);但2组间血清总睾酮水平差异无统计学意义(0.70nmol/L比0.73 nmol/L,均P>0.05).代谢综合征组血清总睾酮与胰岛素、HOMA-IR和HOMA-ISI无明显相关性(r=0.142、r=0.076、r=-0.073,均P>0.05),血清雌酮水平与血清胰岛素、HOMA-IR呈明显负相关(r=-0.546、r=-0.599,均P<0.05),与HOMA-ISI呈明显正相关(r=0.596,P<0.05);血清雌二醇水平与血清胰岛素、HOMA-IR呈明显负相关(r=-0.581、r=-0.623,P<0.01),与HOMA-ISI呈明显正相关(r=0.632,P<0.01).结论 绝经后女性代谢综合征患者雌酮、雌二醇水平明显减低,且与胰岛素抵抗密切相关. Objective To discuss the changes of serum sex hormone levels in postmenopausal women with metabolic syndrome and to explore the relation to insulin resistance. Methods One hundred and twenty eight pa- tients with metabolic symtrome (metabolic syndrome group) and 116 control subjects (control group) were randomly selected fi'om Physical Examination Center in People's Hospital of Rizhao, Shangdong Province from March to December, 2012. The height and body mass were measured to calculate body mass index (BMI) ; the blood pressure, fasting blood glocuse, fasting insulin, blood lipid and sex hormone were detected. Serum testosterone, estradiol and insulin were measured by chemiluminescence method and serum oestrone was measured by enzyme linked immunosorbenl assay. Homeostasis mode] of insulin resistance was used to calculate insulin resistance (HOMA-IR) and sensitivity index (HOMA-ISI). Results The BMI, systolic pressure, diastolic pressure, fast- lug blood glocuse, triglycerides were significantly higher, while high density lipoprotein eholesterin was significant- lv lower in metabolic syndrome group than that in control group [ BMI: (26.6 ± 2.21 kg/m2 vs (22.6 ± 1.6 )kg/m2 , systolic pressure: ( 129 ± 10)mmHg vs (114 ±7)mmHg, diastolic pressure: (85 ±7)mmHg vs (75 ±5)mmHg, fhsting blood glocuse : (6.3 ± 1.3 ) mmol/L vs ( 5.0 ± 0.4 ) retool/L, triglycerides : ( 2. 1 ± 1.2 ) mmol/L vs ( 0.9 ± 0.3 ) retool/L, high density lipoprotein cholesterin : ( 1.36 ± 0.35 ) mmol/L vs ( 1.64 ± 0.24 ) retool/L, all P 〈0.0l]. Compared with control group, insulin and HOMA-IR were significantly increased, while cstradiol, oestrone and HOMA ISI were significantly decreased in metabolic syndrome group ( insulin: 67.34 pmol/L vs 40.58 pmol/L, HOMA-IR: 2.75 vs 1.27, estradiol: 20.80 pmol/L vs 31.52 pmol/L, oestrone: 39.52 pmol/L vs 47.98 pmol/L, HOMA ISI: 0. 016 vs 0. 035 ;P 〈 0.05 or 0.01 ), but no significant difference of testosterone between the two groups was found (0.70 nmol/L vs 0.73 nmoL/L;P 〉 0.05 ). In metabolic syndrome group, the serum level of testosterone was not significantly correlated with insulin, HOMA-IR and HOMA-ISI ( r = 0. 142, 0. 076 3, - 0. 073, all P 〉 0.05 ) ; the serum level of oestrone and estradiol was negatively correlated with insulin (r= -0.546, P〈0.05, r= -0.581, P〈0.01) and HOMA-IR (r= -0.599, P〈0.05, r= -0.623, P〈 0.05), and it was positively correlated with HOMA-ISI (r = 0. 596, P 〈0. 05, r =0.632, P 〈0. 01). Conclusion Levels of endogenous oestrogen and estradiol significantly decrease in postmenopausal women with metabolic syndrome, which are closely correlated to insulin resistance.
出处 《中国医药》 2015年第4期554-558,共5页 China Medicine
关键词 代谢综合征 性激素 胰岛素抵抗 Metabolic syndrome Sex hormones Insulin resistance
  • 相关文献

参考文献23

  • 1Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and withoul C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study [ J ]. Circulation, 2003,108 (4) :414-419.
  • 2Doi Y, Ninomiya T, Hata J, et al. Proposed criteria for metabolic swdrome in Japanese based on prospective evidence: the Hisaya- ma study J . Stroke, 2009,40(4):1187-1194.
  • 3Mukai N, Doi Y, Ninomiya T, et al. hnpact of metabolic syndlmeed with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study [J ]. Diabetes Care, 2009,32(12) :2288-2293.
  • 4刘静,赵冬,王薇,孙佳艺,刘军,王淼,秦兰萍,吴兆苏.中国11省市代谢综合征不同组分及其组合形式与心血管病发病的关系[J].中华流行病学杂志,2008,29(7):652-655. 被引量:26
  • 5Shneidr JG, Tompkins C, Blumenthal RS, et al. The metabolic svndrm in wmen[J].Cardiol Rev, 2006,14 ( 6 ) :286-291.
  • 6Chedraui P, San MiguJel G, Vintimilla-Sigaenza I, et al. The metabol- ic syndrome and its components in postmenopausal women[J ]. Gyneol Endrinol, 2013,29(6) :563-568.
  • 7Jouandch Z, Nayebzadch F, Qorbani M, et al. Metabolic syn- &ome and menopause [ J ]. J Diabetes Metab Disord, 2013, 12(1):1.
  • 8Tsr A. Harman-Bohem I, Buchs AE, et al. The guidelines for tile diagnosis preenlion and treatment of type 2 diabetes mellitus- 2005[J]. Harefuah, 2006,145(8) :583-586,630.
  • 9郭志琴,曹剑,李小鹰,陈荣霞,苗克,张荣强,赵沙沙,薛兰,石海燕.绝经后代谢综合征女性雌激素水平的变化[J].中华老年心脑血管病杂志,2010,12(12):1065-1067. 被引量:8
  • 10Panolopouhs G, Ruiz JC, Raison J, et al. Menopause, fat and leandistribution in obese women[J]. Maturitas, 1996,25( 1 ) :11-19.

二级参考文献17

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3058
  • 2王薇,赵冬,刘静,曾哲淳,孙佳艺,刘军,秦兰萍,吴兆苏.中国35~64岁人群胆固醇水平与10年心血管病发病危险的前瞻性研究[J].中华心血管病杂志,2006,34(2):169-173. 被引量:133
  • 3陈庆瑜,甘小玲,叶枫,袁翠萍,石一洁,刘小珍.女性代谢综合征的临床特征与防治[J].中华全科医师杂志,2006,5(6):366-367. 被引量:8
  • 4《中国成人血脂异常防治指南》制订联合委员会.中国成人血脂异常防治指南.北京:人民卫生出版社,2007.
  • 5Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005,112(17) : 2735-2752.
  • 6Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med, 2006, 119 (10):812- 819.
  • 7Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol, 2007,49(4) :403-414.
  • 8Zhu S, Heymsfield SB, Toyoshima H, et al. Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr,2005,81(2) :409-415.
  • 9Alberti KG, Zimmet P, Shaw J. The metabolic syndrome -a new worldwide definition. Lancet, 2005,366(9491 ) : 1059-1062.
  • 10World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1: Diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization, 1999.

共引文献32

同被引文献8

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部